The Marseille Public Hospitals and the Mediterranean Infection Foundation have reported to the National Agency for the Safety of Medicines and Health Products (ANSM) a new publication deemed problematic by the controversial professor, now retired.
A tiring feeling of repetition. Professor Didier Raoult is once again being pinned for having advertised his favorite product, hydroxychloroquine, in a medical journal. This publication was reported to the health authorities, we learned this Thursday from the APHM, confirming information from Le Point.
The article, published in the August 2024 edition of the journal “Acta Scientific Microbiology”, is co-signed by Didier Raoult, former head of the IHU Méditerranée Infection in Marseille, and one of his former close collaborators, Philippe Brouqui.
This article, based on data from 1,276 Covid patients treated at the IHU, some of whom were treated with hydroxychloroquine, claims to once again demonstrate the effectiveness of this controversial treatment promoted by Professor Raoult.
In their letter, the APHM and the Mediterranean Infection Foundation, which oversees the IHU, “report” and “dissociate” of this article whose methodology is based on “the use of patient data and unauthorized research”specified the APHM. According to the establishment, this report was decided in a “logic of return to normal” at the IHU since the departure of Professor Raoult, now retired.
The ANSM had taken legal action in November 2023 after the publication of another study co-signed by Professor Raoult, which had not obtained the mandatory authorizations. The former head of the IHU and his team are suspected of having conducted several studies “savages” at the IHU during the Covid epidemic.
Related News :